Background: In our previous paper, we demonstrated that Connexin 43 (CX43) was highly expressed in bladder cancer (BC) tissues. But the molecular mechanism about microRNAs (miRNAs) regulation upstream of CX43 in BC has not been well elucidated and remains to be further studied. ) is a tumor suppressor in progression of multifarious cancers including BC. Nevertheless, the underlying mechanisms of CX43/miR-139-5p in tumorigenesis of BC are still not well illustrated. The specific objective of our study was to inquiry the effect of CX43/miR-139-5p on BC progression and its underlying mechanism. Methods: The bioinformatics analysis softwares were applied to predict the miRNAs in the upstream of CX43. First, the expression levels of miR-139-5p in BC tissues (tumor) and paracancer tissues (normal) were investigated using the data from The Cancer Genome Atlas database. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to detect the mRNA expression level of miR-139-5p in three human BC cell lines 5637, T24, ECV-304 and a human bladder epithelial immortalized cell line SV-HUC-1 (normal control). Then si-CX43, si-control, miR-139-5p mimic, and its negative control (NC) were transfected into BC cell line ECV-304. The relationship of miR-139-5p and CX43 was analyzed by dual-luciferase reporter assay. The qRT-PCR and Western blotting were used to test the mRNA and protein expression level of CX43. The proliferation of ECV-304 and T24 cells were examined by cell counting kit-8. The migration and invasion of ECV-304 cells were tested by transwell assay. To determine whether miR-139-5p would affect cell proliferation, migration and invasion by targeting CX43, we executed the rescue assay. The comparison between two groups was analyzed by Student's t test, and comparisons among multiple samples were performed by oneway analysis of variance and a Bonferroni post hoc test. Results: The expression of miR-139-5p was remarkably down-regulated in BC tissues (tumor vs. normal, 2.286 ± 0.017 vs.
Introduction
Bladder cancer (BC), with 549,393 new cases in 2018, is the most familiar malignant tumor in the urinary system of men and women. [1, 2] Because of the introduction of novel diagnostic approaches, the development of imaging and surgical techniques, the hoisting of chemotherapy, as well as the improvement of urinary tumor markers, BC diagnosis and treatment have made some progress in recent decades. [3] However, these treatments have some limitations in clinic and the 5-year survival rate has improved very little. Therefore, the underlying mechanism of BC needs further probe to find more effective treatments for BC.
Connexins (CX), which are found to be highly expressed in various cancers, are composed by 21 proteins, of which Connexin 43 (CX43) is the most rifely expressed and diffusely researched protein. [4] In previous article, the high expression of CX43 was shown in BC tissues. [5] Micro-RNAs (miRNAs), short non-coding RNAs, display momentous modulatory functions in genetic expression. [6] Besides, many miRNAs are engaged in cell survival of cancers. [7, 8] Lin et al [9] reported that miRNA-206 (miR-206) restrained the metastasis of breast cancer cells via modulating CX43. The regulation mechanism of miRNA on CX43 in BC is still unknown. According to Hu et al, [10] up-regulation of miR-139-5p could suppress the effects on BC cells. There were a large body of literatures which were concerned with miR-139-5p acting as a remedial molecule for patients with BC. [11, 12] However, CX43 and miR-139-5p acting together on cancers have not been reported.
This study aimed to explore the biological effect of CX43/miR-139-5p on BC and their potential molecular mechanism.
Methods

Prediction of the miRNAs on upstream of CX43
The miRNA target gene prediction sites miRanda (http:// miranda.org.uk/), miRWalk (http://mirwalk.umm.uni-hei delberg.de/), TargetScan (http://www.targetscan.org/), miRDB (http://mirdb.org/) were used to predict the miRNAs on the upstream of CX43. The miRNAs were obtained from the intersection of the above four sites and the lowly expressed miRNAs in BC analyzed in The Cancer Genome Atlas (TCGA) (https://cancergenome.nih.gov/) database. In this study, we utilized the gene expression profile dataset from the public database TCGA to study the differential expression of miR-139-5p in BC tissues (tumor) and paracancer tissues (normal). The dataset has 437 samples, including 418 BC tissues and 19 normal samples.
Cell culture and transfection
Human BC cell lines 5637, T24, ECV-304 and human bladder epithelial immortalized cell line SV-HUC-1 (normal control) were acquired from American Type Culture Collection (USA). Routine culture was performed using Roswell Park Memorial Institute-1640 medium in a routine culture with penicillin (100 U/mL), streptomycin (0.1 mg/mL), and fetal bovine serum (10%). si-CX43-1 (Forward: 5'-GCCCAAACTGATGGTGT-CAAT-3'), si-CX43-2 (Forward: 5'-CAATTCTTCT-TGCCGCAATTA-3'), si-CX43-3 (Forward: 5'-GCCC-AAACTGATGGTGTCAAT-3'), and si-con (Forward: 5'-AATTCTCCGAACGTGTCACGT-3') were synthesized by Shenzhen Huada Gene Research Institute (Guangdong, China). MiR-139-5p mimic/mimic negative control (NC) was bought from RuiboBio (Guangzhou, China). According to the instructions of Lipofectamine 2000 (Invitrogen, Shanghai, China), transfection was performed. After 24 h, the efficiency of transfection can be observed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR).
qRT-PCR
We extracted total RNA from ECV-304 cells using TRIzol reagent (Invitrogen). For reverse transcription of miRNAs, miScript II RT Kit (QIAGEN, Germany) was used. To determine miR-139-5p expression level by qPCR, MiScript SYBR ® Green PCR Kit (QIAGEN) was used. PrimeScript RT Reagent Kit (Takara, Dalian, China) was used to form complementary DNA for detecting the mRNA expression level of CX43. SYBR ® Premix Ex Taq II (TaKara) was applied to qPCR. U6 expression was used to normalize miR-139-5p expression. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression was used to normalize CX43 expression. 2 ÀDDCt method was used to calculate miR-139-5p and CX43 relative expression levels. All the primers used for qPCR were illustrated in Table 1 .
Western blotting
First, cells were gathered and lysed using radioimmunoprecipitation assay buffer (Beyotime, Jiangsu, China) based on the manufacturer' protocol. Then the membrane was sealed by 5% skim milk powder for 1 h. Following that, the membrane was incubated with the primary antibodies overnight at 4°C. Then, Tris-buffered saline containing 0.1% Tween-20 (Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) was used to wash the membrane three times for 5 min each. The membrane was probed with the secondary antibody for 1 h at room temperature and washed and added enhanced chemiluminescence (ProteinTech Group, Inc., Chicago, IL, USA). GAPDH was used as the internal control. The QUANTITY ONE software (version 4.6.9; Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used to scan the gray value. 
Primers
Sequences
qRT-PCR: Quantitative reverse transcription-polymerase chain reaction; CX43: Connexin 43; MiR-139-5p: MicroRNA-139-5p; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
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Cell counting kit-8
After 24-h transfection, the cells were digested and counted, and a cell suspension was prepared. 100-mL cell suspension was taken into 96-well plates at the standard of 1000 cells per well. Then the cells were incubated in a 37°C incubator with 5% CO 2 for 1.5 h. The 10-mL cell counting kit-8 (CCK-8) reagent (CWBio, Beijing, China) was added to each well. Finally, the optical density at 450 nm excitation light (A 450nm ) was detected every 24 h using the microplate reader.
Transwell migration and invasion experiments
The invasive or migratory capacity of ECV-304 cells was detected using transwell chambers (Merck KGaA, Germany) with or without matrigel (BD Bioscience, CA, USA) in the upper chamber, respectively. After 24 h transfection, cell suspension was prepared and added to the upper chamber (1 Â 10 4 cells for invasion assay and 5 Â 10 3 cells for migration assay). In the lower chamber, 500 mL of complete medium was added. After being kept at 37°C overnight, remanent cells in the upper chamber were wiped off using cotton swab. The invaded or migrated cells on the lower surface were fixed with 4% paraformaldehyde for half an hour and stained with 0.1% crystal violet for 20 min. The invaded and migrated cells were captured under a microscope (Olympus, Tokyo, Japan) and cell numbers were counted in five random fields.
Dual-luciferase vector construction experiment
The transfected cells were planted in 96-well plates (the density was 1 Â 10 4 /well) and cultured for 48 h. MiR-139-5p mimic and its NC, and PGL3-CX43-3'UTR-wild type (wt) (Promega, Madison, Wisconsin, USA) or PGL3-CX43-3'UTR-mutant type (mut) (Promega) were co-transfected into cells using Lipofectamine 2000 (Invitrogen). After 24 h transfection, the luciferase activity was assayed using the Dual-Luciferase Reporter Assay System (Promega). The ratio of the firefly luciferin intensity value to the Renilla fluorescein intensity value was calculated.
Statistical analysis
All experiments were done in duplicate and repeated three times. All data conformed to the normal distribution and the homogeneity of the variance, and were expressed as mean ± standard deviation. The experimental data were analyzed by SPSS 22.0 statistical analysis software (SPSS Inc., Chicago, IL, USA). The comparison between two groups was analyzed by Student's t test. The comparisons among multiple samples were performed by one-way analysis of variance and a Bonferroni post hoc test. P < 0.05 was considered statistically significant.
Results
Low expression of miR-139-5p in BC tissues
To identify potential upstream regulatory miRNAs for CX43, we first used miRanda, miRWalk, TargetScan, and miRDB to predict miRNAs on the upstream of CX43 and 120 miRNAs were obtained from these databases. Then we used the OncomiR website to analyze miRNAs with low expression in BC in the TCGA database and 22 miRNAs were obtained. After that, two common miRNAs (hsa-miR-1 and hsa-miR-139-5p) were obtained from the intersection of 120 miRNAs from the above four software predictions and 22 miRNAs from TCGA database [ Figure 1A ]. Based on comprehensive literature analysis, miR-139-5p was selected as the regulatory miRNA of CX43 for the following study. By analyzing the data about miR-139-5p in OncomiR website, we concluded that miR-139-5p was less expressed in BC tissues (n = 418) than that in paracancer tissues (n = 19) (tumor vs. normal, 2.286 ± 0.017 vs. 3.211 ± 0.034, t = 11.540, P < 0.0001) [ Figure 1B ]. Chinese Medical Journal 2019;132 (19) www.cmj.org
Low expression of miR-139-5p in BC cell lines
We used the qRT-PCR assay to investigate the expression level of miR-139-5p in BC. The results revealed that miR-139-5p was less expressed in BC cell lines than in normal cell lines (P < 0.01 in all BC cell lines), especially the lowest expression of miR-139-5p in ECV-304 cell line. So, ECV-304 cell line was used in the subsequent experiments [ Figure 2A ]. In order to investigate the effect of miR-139-5p on BC, miR-139-5p mimic/mimic NC were transfected into ECV-304 cells. As presented in Figure 2B , miR-139-5p mimic treatment significantly increased miR-139-5p expression, compared with miR-139-5p mimic NC group (P < 0.01).
Effect of over-expressed miR-139-5p on BC cell properties
The over-expression of miR-139-5p in ECV-304 cells was used to further investigate the possible biological roles of miR-139-5p in BC. The results of the CCK8 assay demonstrated that the miR-139-5p mimic group was significantly lower than the other two groups, indicating that over-expression of miR-139-5p restrained the proliferation of ECV-304 (P = 0.001) [ Figure 3A ] and T24 cells (P = 0.005) [ Figure 3B ]. The results revealed that the proliferation of ECV-304 and T24 cells were similar. Therefore, in the following experiments, we chose one cell line of them. As shown in Figure 3C and 3D, the number of crystal violet-stained cells in the invasion/migration assay was lessened in miR-139-5p mimic groups than in miR-139-5p mimic NC groups (P = 0.001, P = 0.001), presenting that over-expression of miR-139-5p suppressed the invasion and migration of ECV-304 cells. The results in this chapter indicated that over-expression of miR-139-5p restrained the properties of BC cells.
Possible binding sites of CX43 for miR-139-5p
To identify the potential miRNAs targeting CX43 mRNA, we utilized the miRanda, miRWalk, TargetScan, and miRDB algorithm to detect the sequence of CX43 mRNA. MiR-139-5p was authenticated as an altitudinal reliance candidate [ Figure 4A ]. To detect the targeting between miR-139-5p and CX43, CX43-wt and CX43-mut, targeting sequences were cloned to the luciferase on-limits reading frame [ Figure 4A ]. The relative luciferase activity of CX43-wt construct was distinctly lessened by upregulation of miR-139-5p (miR-139-5p mimic NC vs. miR-139-5p mimic, 0.916 ± 0.063 vs. 0.356 ± 0.048, t = 7.085, P = 0.002), nevertheless in the same conditions, the activity of CX43-mut construct was untouched (miR-139-5p mimic NC vs. miR-139-5p mimic, 0.918 ± 0.057 vs. 0.878 ± 0.039, t = 0.577, P = 0.595) [ Figure 4B ]. By qRT-PCR and Western blotting, we discovered that the mRNA (P = 0.005) and protein (P = 0.002) expression of CX43 in ECV-304 cells declined dramatically in miR-139-5p mimic group compared to the miR-139-5p mimic NC group [ Figure 4C -E]. These results verified that CX43 was a direct target of miR-139-5p, which was negatively regulated by miR-139-5p.
CX43 deletion strengthened inhibitory effect of miR-139-5p in BC cells
To further manifest whether miR-139-5p displayed its function via targeting CX43, we designed co-transfection of CX43 knockdown combined with miR-139-5p mimic. CCK8 results indicated that over-expression of miR-139-5p suppressed the ECV-304 cell proliferation (P < 0.01), and CX43 silence accelerated the elevated role of miR-139-5p on the proliferation of ECV-304 cells (P < 0.01) [ Figure 5A ]. Transwell assay results revealed that CX43 silence stressed the inhibitory influence of miR-139-5p on the invasion (P = 0.028) and migration (P = 0.014) of BC cells [ Figure 5B and 5C]. Together these results provide important insights into that CX43 ablation enhanced the inhibitory effect of miR-139-5p on cell proliferation, invasion, and migration in BC cells.
Discussion
In our present paper, we observed that miR-139-5p was lowly expressed in BC tissues. Besides, miR-139-5p was Chinese Medical Journal 2019;132 (19) www.cmj.org lowly expressed in BC cell lines and over-expression of miR-139-5p could alleviate the property of BC cells. Moreover, CX43 was a direct target of miR-139-5p and CX43 deletion could strengthen the inhibitory effect of miR-139-5p in BC cells.
The proteins of CX family constitute the gap junction channel. The channel admits diminutive molecules to pass first-hand among neighboring cells and they are metabolically and electrically coupled. [13, 14] In human, CX are constituted of 21 proteins, among which ten CX genes mutations are associated with 28 different genetic diseases. Six of these diseases are ascribed to CX43 mutations. [14, 15] Recent evidence suggested that after pernicious transformation of cancers, the aberrant regulation of CX and its role in cellular communication might reinforce or restrain tumorigenesis and metastasis. [16] CX43, as a member of CX family, was alleviated in a few of solid tumors, including breast cancer, [17] ovarian cancer, [18] and lung cancer. [19] In our previous study, we found that CX43 was highly expressed in BC tissues. [5, 20] Once again, we verified that CX43 might be a potential target for BC treatment.
To predict potential upstream regulatory miRNAs for CX43, we used four prediction softwares miRanda, miRWalk, TargetScan, and miRDB and found that miR-139-5p is one of the miRNAs on the upstream of CX43. Increasing evidences have illustrated that miRs could administer the expression of many genes by replenishing the target mRNAs 3 0 UTR. We then verified that miR-139-5p could direct bind to the 3 0 UTR of CX43 by luciferase reporter assay. MiRNAs, about 22 nucleotides in length, are the same category of diminutive non-coding cellular RNAs and can suppress their target genes via dehiscing Chinese Medical Journal 2019;132 (19) www.cmj.org mRNA molecule or restraining their translation to disturb the post-transcriptional pathways. [21] Growing evidences have revealed that many miRs have been deemed as cancer regulators. [22, 23] It has previously been observed that CX43 and/or miR-125b may be remedial targets for human breast cancer. [24] It was indicated that miR-1 targeted CX43 expression to regulate the vascular tutelar effect of angiotensin II. [25] However, there are few reports on the role of miR-139-5p in CX43 expression. Our study demonstrated that miR-139-5p was a direct target of CX43 and CX43 deletion could strengthen the inhibitory effect of miR-139-5p in BC cells.
Our results also indicated that miR-139-5p over-expression restrained the proliferation, invasion, and migration of BC cells. Increasing number of articles evidenced that many miRs may act as tumor-promoters or tumorinhibitors, [26] such as miR-146b [27] and miR-373 [28] function as tumor-promoters, conversely miR-27a [29] and miR-34b-3p [30] function as tumor-inhibitors in BC. Some researches hold the views that miR-139-5p, as a tumor-inhibitor and a latent modulatory miRNA, is normally down-graded in pernicious cancers, such as non-small cell lung cancer, [31] endometrial cancer, [32] colorectal cancer, [33] and BC. [11] Consistent with previous researches, in this paper, we revealed that over-expression of miR-139-5p was dramatically lessened in BC tissues and cell lines. Moreover, restraining of miR-139-5p could recover the inhibitory influences on proliferation, invasion, and migration of BC cell. These suggested that miR-139-5p played as a tumor-inhibitor in BC progression and metastasis.
In general, we demonstrated that miR-139-5p was downregulated in BC tissues and cell lines. In addition, miR-139-5p may function as a miRNA on the upstream of CX43.
Besides, over-expression of miR-139-5p alleviated cell proliferation and metastasis of BC. Furthermore, CX43 mediated the effects of miR-139-5p on cell proliferation, invasion, and migration in BC cells. Therefore, these findings hinted that miR-139-5p and CX43 hold significant potential to serve as therapeutic molecules for BC. However, there are some limitations in our study. This is just a preliminary experiment in the role of CX43 and miR-139-5p on BC. It may need more experiments in other cell lines to support our findings. Moreover, the in-vivo experimental studies are needed to further confirm our results. These experiments are in progress, which will be reported in future articles.
